Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND5 pseudogene 25 (MTND5P25) is a nuclear sequence derived from the mitochondrial gene that encodes NADH:ubiquinone oxidoreductase core subunit 5, a protein involved in the mitochondrial respiratory chain complex I[2][4][5]. Unlike the functional mitochondrial ND5 gene, MTND5P25 contains numerous mutations (e.g., frameshifts and premature stop codons)[5] and does not encode a functional protein. Such pseudogenes are created via transfer of mitochondrial DNA fragments to the nucleus and can be detected by PCR, but do not contribute to cellular metabolism or disease directly. They are not considered valid drug targets or biomarkers in current biomedical research[5].\n\nIf you require information about the active mitochondrial ND5 gene (rather than the pseudogene), it is a core subunit of respiratory chain complex I with established biological and disease relevance[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND5 pseudogene 25 (MTND5P25).